The Valley Desk

NCT02537444 · Interventional trial

Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)

Overall registry status Completed

Phase 2

Conditions Ovarian Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov